No Data
SymbolStock Name
Latest PriceChg%ChgVolumeTurnoverOpenPre CloseHighLowMarket CapFloat CapSharesShs Float5D %Chg10D %Chg20D %Chg60D % Chg120D %Chg250D %Chg% Year-to-dateDiv YieldTTMTurnover RatioP/E (TTM)P/E (Static)AmplitudeIndustry
US OptionsDetailed Quotes
BEN240719P25000
- 1.45
- +0.10+7.41%
15min DelayClose Jul 19 15:59 ET
1.45High1.45Low
1.45Open1.35Pre Close1 Volume419 Open Interest25.00Strike Price145.00Turnover1365.48%IV-0.26%PremiumJul 19, 2024Expiry Date1.51Intrinsic Value100Multiplier0DDays to Expiry0.00Extrinsic Value100Contract SizeAmericanOptions Type-0.6484Delta0.1142Gamma10.56Leverage Ratio-16.4225Theta0.0000Rho-6.85Eff Leverage0.0009Vega
Intraday
- 5D
- Daily
News
Putnam Investments Announces Transfer of Closed-End Fund Management Contracts to Franklin Advisers
BOSTON--(BUSINESS WIRE)--Effective July 15, 2024, Putnam Investment Management, LLC ("Putnam Management") has transferred its management contracts with the Putnam closed-end funds to Franklin
Clarion Partners Real Estate Income Fund Inc. Announces Results of Tender Offer
NEW YORK--(BUSINESS WIRE)--Clarion Partners Real Estate Income Fund Inc. (the "Fund") Class S Shares (CPRSX), Class T Shares (CPRTX), Class D Shares (CPRDX) and Class I Shares (CPREX) announced
What to Expect From Franklin Resources' Next Quarterly Earnings Report
Jackie VanderBrug Receives 2024 Joan Bavaria Award
NORTHAMPTON, MA / ACCESSWIRE / July 16, 2024 / Franklin TempletonPutnam Investments' Jackie VanderBrug has been announced as one of three winners of the 2024 Joan Bavaria Award, which is awarded for
Charles M. Royce to Become Senior Advisor at Royce Investment Partners
NEW YORK, July 15, 2024 /PRNewswire/ -- Celebrating his 51st year at Royce Investment Partners, Charles M. Royce will become a Senior Advisor at Royce Investment Partners ("Royce") effective
Most Shorted S&P 500 Financial Stocks
Comments
Morning mooers! It is Monday, April 29th, and the market is open and chugging away on most recent earnings. This week is the most jam packed earnings week so far, with 175 firms in the S&P 500 reporting.
My name is Kevin Travers, and I am writing this update from the Nasdaq offices in Times Square, where moomooo is holding a partnership event! Tune in to the live tab to see the presentations and KOL features.
Here are your morning moovers:...
My name is Kevin Travers, and I am writing this update from the Nasdaq offices in Times Square, where moomooo is holding a partnership event! Tune in to the live tab to see the presentations and KOL features.
Here are your morning moovers:...
14
$Amylyx Pharmaceuticals(AMLX.US$
I have no doubt in Franklin, especially when both are together in one stock![]()
. I think both $Franklin Resources(BEN.US$ and $Franklin Biotechnology Discovery Fund(LU0109394709.MF$ are here. I don't know the second one could not link to AMLX.US, is it his holding company?
Relyvrio is approved in the US, Albrioza in Canada. AKA Phoenix.
Pegasus (Phase 2) is in there for Alzheimer. Helios (Phase 2) for Wolfram Syndrome and Orion (P...
I have no doubt in Franklin, especially when both are together in one stock
Relyvrio is approved in the US, Albrioza in Canada. AKA Phoenix.
Pegasus (Phase 2) is in there for Alzheimer. Helios (Phase 2) for Wolfram Syndrome and Orion (P...
2
Insider selling, especially the large scale by Alok Sethi and lack of buying in past year, creates concern despite high level of insider ownership. The sale above the current share price does not reveal insider sentiment about company value.
Franklin Templeton eyes significant growth in Canada, expecting Andrew Ashton's expertise to fuel expansion. The potential acquisition of Putnam Investments may unlock new opportunities.
Market overreactions and irrational behavior of investors may lead to discrepancies between a company's fundamentals and its stock performance. The drop in Franklin Resources' stock may be due to past unreasonable growth expectations or a potential one-off gain or loss that is ignored.
Read more